# sicklecell gvhd qol mpnsm hemonc vitt

Our first issue of 2022 is live! 🎉

Featuring trials in & a study on in a review on drug-drug interactions between targeted therapies & antifungals, and more! https://t.co/ncz5PtUKup

20 80
2021-12-29